Each NeuroPI module is prepared by distinguished faculty who are acknowledged leaders in their respective fields. Each module is composed of a set of multiple-choice items with preferred response, instructions on how to collect cases to assess one's practice, and resources for creating and implementing an effective improvement plan. Participants are able to compare their performance pre- and post intervention to assess what changes have occurred in their practice.
Members: FREE $199.00*
*Free access is limited to one course at a time for eligible members.
- Assess performance via chart audit comparing current performance with measures and best practices in order to select improvements to make.
- Consult educational resources related to the measure(s) selected for improvement, design an intervention, and implement an improvement plan.
- Re-evaluate performance via chart comparing current practice with measures and best practices to determine whether improvement goals have been achieved.
- Summarize practice, process and/or outcome changes resulting from the activity.
- Annual Parkinson disease diagnostic review
- Annual psychiatric disorders or disturbances assessment
- Annual cognitive impairment or dysfunction assessment
- Annual querying about sleep disturbances
- Querying about Parkinson’s disease medication-related motor complications at all visits
As a result of this program, the participant will determine individual practice gaps and address them through a performance improvement plan designed to improve competence, performance, and patient outcomes.
- Interpersonal Skills and Communication
- Medical Knowledge
- Patient Care
- Practice-based Learning and Improvement
Date of Release
December 26, 2014
This module is eligible for CME credits for three years from the release date.
NeuroPI Data Terms & Conditions
The American Academy of Neurology Institute (AANI) no longer requires You (NeuroPI and aan.com user) to provide full date of service (day/month/year); only year of service will be transmitted to and stored by AANI. All previously collected "day" and "month" from date of service records have been deleted from the AANI's NeuroPI database. Accordingly, for NeuroPI, AANI is not requesting or storing any "protected health information" or "limited data sets" as defined by the regulations issued under the Health Insurance Portability and Accountability Act of 1996. The patient data You submit to the AANI through NeuroPI is de-identified health information. You must track patients separately from NeuroPI. Within the NeuroPI modules, Your patients will be identified using a 4-digit patient code that You create. Any other identifying information is strictly prohibited. Please use the NeuroPI Patient Tracker to create Your 4-digit patient codes for Your personal reference. The NeuroPI Patient Tracker must not be shared with AANI.
The American Academy of Neurology Institute either owns or has permission to use all of the NeuroPI module content. You may use these modules for your personal, noncommercial use, but please send permissions requests for any other uses to NeuroPI@aan.com. All of the individual de-identified health information you submit to the AANI through NeuroPI is confidential. Your maintenance of certification ("MOC") credit information is transmitted to the American Board of Psychiatry and Neurology (ABPN) once You've completed a module. You can opt-out of this service in NeuroTracker. Please note, AANI is not a certifying board and members are encouraged to contact ABPN for the most up-to-date information on MOC requirements. You acknowledge that AANI is and shall be deemed the owner of all rights to the aggregate, de-identified data submitted to NeuroPI and subsets of the aggregate data, any and all reports based on the aggregate, de-identified data, and all trademarks and trade secrets arising from or reflected in NeuroPI (collectively, "Aggregate Data"), with the exception of your individual data. AANI has full and unencumbered rights to publish, disclose, distribute, market, sell, and create derivatives of, Aggregate Data in any form.
KATHLEEN M. SHANNON, MD
Professor, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL
*Dr. Shannon has nothing to disclose.
JANIS MIYASAKI, MD, MEd, FRCPC
Associate Professor, University of Alberta, Walter C. Mackenzie Health Science Centre, Edmonton, Alberta, Canada
*Dr. Miyasaki has received personal compensation for activities with Novartis and Teva Neuroscience as a consultant and/or data safety monitoring board member. Dr. Miyasaki has received research support from the National Institutes of Health.
DONALD J. IVERSON, MD, FAAN
Humboldt Neurological Medical Group, Eureka, California
*Dr. Iverson has received personal compensation for participation in the Accorda Therapeutics speaker's bureau.
RALPH F. JOZEFOWICZ, MD, FAAN
Chair, PIP Taskforce
University of Rochester, Rochester, New York
*Dr. Jozefowicz has received personal compensation in an editorial capacity for The Neurologist.
CYNTHIA L. COMELLA, MD, FAAN
Education Committee Chair
Rush University Medical Center, Chicago, Illinois
*Dr. Comella has received personal compensation for activities with Ipsen, Merz, Allergan, Inc., Medtronic, Inc., Teva Neuroscience, US World Meds, and Impax. Dr. Comella has received research support from Ipsen, Merz, Allergan, Inc., NIH, Dystonia Coalition, and Dystonia Medical Research Foundation.
JONATHAN P. HOSEY, MD, FAAN
Practice Committee Chair
Geisinger Medical Center, Danville, Pennsylvania
*Dr. Hosey has nothing to disclose.
Tracy King, MA, Associate Director, Education
*Ms. King has nothing to disclose.
Susan Rodmyre, Director, Education
*Ms. Rodmyre has nothing to disclose.
+ Unlabeled Use of Products/Investigational Use Disclosure